Archives

by in
Entry Author Date Location
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
Harvard Professor Steps Down to Pilot Warp Drive Bio 07/02/13 Boston
Infinity Pharmaceuticals Bounces Back To Compete in Crowded Field 02/08/13 Boston
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
Infinity Offers Hint Of Effect With Pancreatic Cancer Drug 01/20/12 Boston
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO 11/03/11 Boston
Infinity Dares to Think Big Against Pancreatic Cancer, Prepares to Show Early Results This Weekend 06/02/11 Boston
Infinity Pharma, Intellikine Strike Deal to Make Cancer Drugs Against Hot Target 07/08/10 Boston
Infinity’s New CEO, Veteran Dealmaker, Seeks to Deliver on Company’s Early Promise 02/09/10 Boston
Infinity Sees Comeback Potential for Cancer Drug that Failed 06/01/09 Boston
Infinity Pharmaceuticals Gets Back Full Rights to Cancer Drugs From AstraZeneca 12/11/08 Boston
Page 1 of 1